|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 611 for Tnfaip3

0.039s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2769723
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2853323
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915528
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal day 6-7
Specimen Label: P6/7
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915528
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal day 8-10
Specimen Label: P8/10
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2845723
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2845723
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Female
Emaps: EMAPS:1795023
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:1795023
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: false
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1869223
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:4844599
Assay Type: RNA in situ
Annotation Date: 2010-12-22
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:1610517
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:4848506
Age: embryonic day 10.5
Specimen Label: Table S4 - E10.5
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1647028
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal day 6
Note: Expression was widespread.
Specimen Label: CNS
Detected: true
Specimen Num: 8
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2854023
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915726
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:3585312
Age: embryonic day 18.0
Note: Expression was detected in the outer neuroblastic layer.
Specimen Label: E18
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915727
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:3585312
Age: postnatal day 0-1
Note: Expression was detected in the outer neuroblastic layer.
Specimen Label: P0/1
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915727
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:3585312
Age: postnatal day 2-3
Note: Expression was detected in the outer neuroblastic layer.
Specimen Label: P2/3
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal day 4-5
Note: Expression was detected in the outer neuroblastic layer.
Specimen Label: P4/5
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal day 6-7
Specimen Label: P6/7
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1915728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal day 8-10
Specimen Label: P8/10
Detected: true
Specimen Num: 6
GXD Expression  
Probe: MGI:1359229
Assay Type: RNA in situ
Annotation Date: 2005-08-30
Strength: Present
Sex: Male
Emaps: EMAPS:1915728
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:3585312
Age: postnatal adult
Note: Expression was detected in the inner segment.
Specimen Label: Adult
Detected: true
Specimen Num: 7
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2762123
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2762123
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1797223
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:1832123
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1832123
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2851823
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2851823
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2760523
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2760523
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2852723
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2852723
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2874723
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:2850023
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:2850023
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9363
Specimen Label: GUDMAP:9363
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:4879273
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Female
Emaps: EMAPS:1796223
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5540974
Age: embryonic day 15.5
Image: GUDMAP:9362
Specimen Label: GUDMAP:9362
Detected: true
Specimen Num: 1
Publication
First Author: Li Y
Year: 2013
Journal: J Biol Chem
Title: Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species.
Volume: 288
Issue: 23
Pages: 16225-34
Publication
First Author: Glowacka WK
Year: 2012
Journal: J Biol Chem
Title: LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages.
Volume: 287
Issue: 33
Pages: 27691-702
Publication  
First Author: Vereecke L
Year: 2014
Journal: Nat Commun
Title: A20 controls intestinal homeostasis through cell-specific activities.
Volume: 5
Pages: 5103
Publication
First Author: Maelfait J
Year: 2012
Journal: PLoS Pathog
Title: A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.
Volume: 8
Issue: 3
Pages: e1002570
Publication
First Author: Lee JY
Year: 2017
Journal: FEBS Lett
Title: The deubiquitinating enzyme, ubiquitin-specific peptidase 50, regulates inflammasome activation by targeting the ASC adaptor protein.
Volume: 591
Issue: 3
Pages: 479-490
Publication
First Author: Dalal NV
Year: 2012
Journal: Neurosci Lett
Title: RNF11 modulates microglia activation through NF-κB signalling cascade.
Volume: 528
Issue: 2
Pages: 174-9
Publication
First Author: Tewari M
Year: 1995
Journal: J Immunol
Title: Lymphoid expression and regulation of A20, an inhibitor of programmed cell death.
Volume: 154
Issue: 4
Pages: 1699-706
Publication
First Author: Drennan MB
Year: 2016
Journal: J Exp Med
Title: NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20.
Volume: 213
Issue: 10
Pages: 1973-81
Publication
First Author: Liang J
Year: 2016
Journal: Cell Rep
Title: Inflammatory Th1 and Th17 in the Intestine Are Each Driven by Functionally Specialized Dendritic Cells with Distinct Requirements for MyD88.
Volume: 17
Issue: 5
Pages: 1330-1343
Publication
First Author: Hammer GE
Year: 2011
Journal: Nat Immunol
Title: Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis.
Volume: 12
Issue: 12
Pages: 1184-93
Publication  
First Author: Kawano M
Year: 2019
Journal: Front Immunol
Title: Lactobacillus helveticus SBT2171 Induces A20 Expression via Toll-Like Receptor 2 Signaling and Inhibits the Lipopolysaccharide-Induced Activation of Nuclear Factor-kappa B and Mitogen-Activated Protein Kinases in Peritoneal Macrophages.
Volume: 10
Pages: 845
Publication
First Author: Talpin A
Year: 2019
Journal: PLoS One
Title: A20 in dendritic cells restrains intestinal anti-bacterial peptide expression and preserves commensal homeostasis.
Volume: 14
Issue: 7
Pages: e0218999
Publication
First Author: Catrysse L
Year: 2016
Journal: Cell Death Dis
Title: A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death.
Volume: 7
Issue: 6
Pages: e2250
Publication
First Author: Charan RA
Year: 2012
Journal: FASEB J
Title: Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Volume: 26
Issue: 2
Pages: 587-95
Publication  
First Author: Pu T
Year: 2021
Journal: Int Immunopharmacol
Title: A20 functions as a negative regulator in macrophage for DSS-induced colitis.
Volume: 97
Pages: 107804
Publication
First Author: Wolfrum S
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes.
Volume: 104
Issue: 47
Pages: 18601-6
Publication
First Author: Slowicka K
Year: 2019
Journal: Nat Commun
Title: Physical and functional interaction between A20 and ATG16L1-WD40 domain in the control of intestinal homeostasis.
Volume: 10
Issue: 1
Pages: 1834
Publication
First Author: Idel S
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: A20, a regulator of NFkappaB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains.
Volume: 100
Issue: 24
Pages: 14235-40
Publication
First Author: Garrett NE 3rd
Year: 2017
Journal: Mamm Genome
Title: Genetic analysis of a mouse cross implicates an anti-inflammatory gene in control of atherosclerosis susceptibility.
Volume: 28
Issue: 3-4
Pages: 90-99
Publication
First Author: Oshima N
Year: 2010
Journal: Clin Exp Immunol
Title: A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.
Volume: 159
Issue: 2
Pages: 185-98
Publication
First Author: Longo CR
Year: 2005
Journal: Hepatology
Title: A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism.
Volume: 42
Issue: 1
Pages: 156-64
Publication
First Author: Coornaert B
Year: 2008
Journal: Nat Immunol
Title: T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.
Volume: 9
Issue: 3
Pages: 263-71
Publication
First Author: Werner SL
Year: 2008
Journal: Genes Dev
Title: Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20.
Volume: 22
Issue: 15
Pages: 2093-101
Publication
First Author: Gupta AK
Year: 2017
Journal: FASEB J
Title: Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2.
Volume: 31
Issue: 11
Pages: 5087-5101
Publication
First Author: Chen M
Year: 2020
Journal: Exp Cell Res
Title: A20 attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting NF-κB activation and pulmonary artery smooth muscle cell proliferation.
Volume: 390
Issue: 2
Pages: 111982
Publication
First Author: Newton K
Year: 2016
Journal: Cell Death Differ
Title: RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Volume: 23
Issue: 9
Pages: 1565-76
Publication
First Author: Onizawa M
Year: 2015
Journal: Nat Immunol
Title: The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.
Volume: 16
Issue: 6
Pages: 618-27
Publication
First Author: Shao L
Year: 2013
Journal: PLoS One
Title: A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis.
Volume: 8
Issue: 5
Pages: e62223
Publication  
First Author: Matsuda H
Year: 2022
Journal: Biochem Biophys Res Commun
Title: Nickel particles are present in Crohn's disease tissue and exacerbate intestinal inflammation in IBD susceptible mice.
Volume: 592
Pages: 74-80
Publication
First Author: Li L
Year: 2009
Journal: Biochim Biophys Acta
Title: The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation.
Volume: 1793
Issue: 2
Pages: 346-53
Publication
First Author: Nakagawa MM
Year: 2018
Journal: Cell Rep
Title: Constitutive Activation of the Canonical NF-κB Pathway Leads to Bone Marrow Failure and Induction of Erythroid Signature in Hematopoietic Stem Cells.
Volume: 25
Issue: 8
Pages: 2094-2109.e4
Publication
First Author: Tiruppathi C
Year: 2014
Journal: Nat Immunol
Title: The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation.
Volume: 15
Issue: 3
Pages: 239-47
Publication
First Author: Van Damme KFA
Year: 2023
Journal: Sci Rep
Title: Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.
Volume: 13
Issue: 1
Pages: 17992
Publication
First Author: Nakagawa MM
Year: 2015
Journal: J Exp Med
Title: Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence.
Volume: 212
Issue: 2
Pages: 203-16
Publication      
First Author: Holgado A
Year: 2023
Journal: J Allergy Clin Immunol
Title: A20 is a master switch of IL-33 signaling in macrophages and determines IL-33-induced lung immunity.
Publication    
First Author: Iorga A
Year: 2021
Journal: J Biol Chem
Title: Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity.
Pages: 100300
Publication
First Author: Boone DL
Year: 2004
Journal: Nat Immunol
Title: The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Volume: 5
Issue: 10
Pages: 1052-60
Publication
First Author: Hitotsumatsu O
Year: 2008
Journal: Immunity
Title: The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
Volume: 28
Issue: 3
Pages: 381-90
Publication
First Author: Heger K
Year: 2014
Journal: PLoS Biol
Title: A20-deficient mast cells exacerbate inflammatory responses in vivo.
Volume: 12
Issue: 1
Pages: e1001762
Publication  
First Author: Liang J
Year: 2020
Journal: Infect Immun
Title: The Ubiquitin-Modifying Enzyme A20 Terminates C-Type Lectin Receptor Signals and Is a Suppressor of Host Defense against Systemic Fungal Infection.
Volume: 88
Issue: 9
Publication
First Author: Vereecke L
Year: 2010
Journal: J Exp Med
Title: Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.
Volume: 207
Issue: 7
Pages: 1513-23
Publication
First Author: Turer EE
Year: 2008
Journal: J Exp Med
Title: Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.
Volume: 205
Issue: 2
Pages: 451-64
Publication
First Author: Lippens S
Year: 2011
Journal: Cell Death Differ
Title: Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Volume: 18
Issue: 12
Pages: 1845-53
Publication
First Author: Valdearcos M
Year: 2017
Journal: Cell Metab
Title: Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility.
Volume: 26
Issue: 1
Pages: 185-197.e3
Publication
First Author: Douglass JD
Year: 2023
Journal: Cell Metab
Title: Obesity-associated microglial inflammatory activation paradoxically improves glucose tolerance.
Volume: 35
Issue: 9
Pages: 1613-1629.e8
Publication
First Author: Hand LE
Year: 2015
Journal: Diabetes
Title: Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit.
Volume: 64
Issue: 1
Pages: 128-36
Publication
First Author: Lee EG
Year: 2000
Journal: Science
Title: Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.
Volume: 289
Issue: 5488
Pages: 2350-4
Publication
First Author: Nakagawa MM
Year: 2019
Journal: Sci Rep
Title: A20 deficiency in hematopoietic stem cells causes lymphopenia and myeloproliferation due to elevated Interferon-γ signals.
Volume: 9
Issue: 1
Pages: 12658
Publication
First Author: Lu TT
Year: 2013
Journal: Immunity
Title: Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
Volume: 38
Issue: 5
Pages: 896-905
Publication
First Author: Shembade N
Year: 2007
Journal: EMBO J
Title: Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.
Volume: 26
Issue: 17
Pages: 3910-22
Publication
First Author: Shi CS
Year: 2010
Journal: Sci Signal
Title: TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy.
Volume: 3
Issue: 123
Pages: ra42
Publication
First Author: Sass G
Year: 2007
Journal: J Immunol
Title: TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax.
Volume: 179
Issue: 10
Pages: 7042-9
Publication
First Author: Schito ML
Year: 1998
Journal: Parasitol Res
Title: Major histocompatibility complex class I- and II-deficient knock-out mice are resistant to primary but susceptible to secondary Eimeria papillata infections.
Volume: 84
Issue: 5
Pages: 394-8
Publication
First Author: Antonia RJ
Year: 2022
Journal: J Cell Mol Med
Title: STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20.
Volume: 26
Issue: 16
Pages: 4591-4601
Publication
First Author: Vetters J
Year: 2019
Journal: J Exp Med
Title: The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF.
Volume: 216
Issue: 9
Pages: 2010-2023
Publication
First Author: Patel S
Year: 2020
Journal: Cell Death Differ
Title: RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases.
Volume: 27
Issue: 1
Pages: 161-175
Publication  
First Author: Kanayama M
Year: 2015
Journal: Nat Commun
Title: Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity.
Volume: 6
Pages: 5779
Publication
First Author: Voet S
Year: 2018
Journal: Nat Commun
Title: A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation.
Volume: 9
Issue: 1
Pages: 2036
Publication
First Author: Liu J
Year: 2014
Journal: Nat Immunol
Title: Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO.
Volume: 15
Issue: 7
Pages: 612-22
Publication
First Author: Walle LV
Year: 2014
Journal: Nature
Title: Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis.
Volume: 512
Issue: 7512
Pages: 69-73
Publication
First Author: Razani B
Year: 2020
Journal: Nat Immunol
Title: Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation.
Volume: 21
Issue: 4
Pages: 422-433
Publication
First Author: Shembade N
Year: 2008
Journal: Nat Immunol
Title: The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20.
Volume: 9
Issue: 3
Pages: 254-62
Publication
First Author: Iha H
Year: 2008
Journal: EMBO J
Title: Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation.
Volume: 27
Issue: 4
Pages: 629-41
Publication
First Author: Lee JH
Year: 2017
Journal: Nat Cell Biol
Title: A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1.
Volume: 19
Issue: 10
Pages: 1260-1273
Publication
First Author: Dansky HM
Year: 2002
Journal: Genetics
Title: A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse.
Volume: 160
Issue: 4
Pages: 1599-608
Publication
First Author: Catrysse L
Year: 2021
Journal: Cell Rep
Title: A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism.
Volume: 36
Issue: 12
Pages: 109748